Emergence of Panton-Valentine leukocidin positive community-acquired methycillin-resistance Staphylococcus aureus - Status of infection and bacteriological features -

Japanese Journal of Chemotherapy

Volumn 52, Issue 11, 2004, Pages 635-653

  Yamamoto, Tatsuo ^a   Taneike, Ikue ^a   Nakagawa, Saori ^a   Iwakura, Nobuhiro ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Community acquired infection; MRSA; Multilocus sequence typing; Panton Valentine leukocidin; Staphylococcal cassette chromosome mec

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHEM DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; LEUKOCIDIN; METICILLIN; MINOCYCLINE; NAFCILLIN; OFLOXACIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; SPECTINOMYCIN; TEICOPLANIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ALLELE; ANTIBIOTIC SENSITIVITY; ASIA; AUSTRALIA; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL FEATURE; COMMUNICABLE DISEASE; DEATH; DISEASE ASSOCIATION; EUROPE; GENETIC ANALYSIS; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PACIFIC ISLANDS; PATHOGENESIS; PNEUMONIA; POPULATION DISTRIBUTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; UNITED STATES;

EID: 11044225200     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Tacconelli E, Tumbarello M, Cauda R: Staphylococcus aureus infections. N Engl J Med 339: 2026-2027, 1998
2. Lee K P, Zipoli T M, Weinberg N A, et al: Staphylococcus aureus, Streptococcus, and Other Gram-Positive Bacteria. In Fitzpatrick's Dermatology in general medicine, 6th ed (Freedberg M I, Eisen Z A, Wolff K, et al eds), p. 1856-1877, McGRAW-HILL, New York, 2003
3. Takahashi N, Nishida H, Kato H, et al: Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351: 1614-1619, 1998
4. Brumfitt W, Hamilton-Miller J M: Methicillin-resistant Staphylococcus aureus. N Engl J Med 320: 1188-1196, 1989
5. Voss A, Doebbeling N B: The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 5: 101-106, 1995
6. Centers for Disease Control and Prevention: Community-acquired methicillin-resistant Staphylococcus aureus infections - Michigan. Morb Mortal Wkly Rep 30: 185-187, 1981
7. Centers for community-acquired Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morb Mortal Wkly Rep 48: 707-710, 1999
8. Dufour P, Gillet Y, Bes M, et al: Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35: 819-824, 2002
9. Vandenesch F, Naimi T, Enright M C, et al: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978-984, 2003
10. Wang C C, Lo W T, Chu M L, et al: Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 39: 481-487, 2004
11. Yamamoto T: Panton-Valentine leukocidin positive community-acquired MRSA infection in Japan. Euro Surveill Wkly 8: issue 27, 2004
12. Witte W, Cuny C, Strommenger B, et al: Emergence of a new community acquired MRSA strain in Germany. Euro Surveill 9: 16-18, 2004
13. Naimi T S, LeDell K H, Como-Sabetti K, et al: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976-2984, 2003
14. Moreno F, Crisp F, Jorgensen J H, et al: Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 21: 1308-1312, 1995
15. Bukharie H A, Abdelhadi M S, Saeed I A, et al: Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 40: 1-4, 2001
16. Campbell K M, Vaughn A F, Russell K L, et al: Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 42: 4050-4053, 2004
17. Centers for Disease Control and Prevention: Community-associated methicillin-resistant Staphylacoccus aureus infections in Pacific Islanders - Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 53: 767-770, 2004
18. Iyer S, Jones D H: Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 50: 854-858, 2004
19. Eady E A, Cove J H: Staphylococcal resistance revisited: community-aquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16: 103-124, 2003
20. Lina G, Piémont, Godial-Gamot F, et al: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128-1132, 1999
21. Oliveira D C, de Lencastre H: Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 46: 2155-2161, 2002
22. Ito T, Ma X X, Takeuchi F, et al: Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC . Antimicrob Agents Chemother 48: 2637-2651, 2004
23. Okuma K, Iwakawa K, Turnidge J D, et al: Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40: 4289-4294, 2002
24. Shukla S K, Stemper M E, Ramaswamy S V, et al: Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin. J Clin Microbiol 42: 3752-3757, 2004
25. Francois P, Renzi G, Pittet D, et al: A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol 42: 3309-3312, 2004
26. Diep B A, Sensabaugh G F, Somboona N S, et al: Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leukocidin. J Clin Microbiol 42: 2080-2084, 2004
27. McDougal L K, Steward C D, Killgore G E, et al: Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41: 5113-5120, 2003
28. Enright M C, Day N P J, Davies C E, et al: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38: 1008-1015, 2000
29. Koreen L, Ramaswamy S V, Graviss E A, et al: Spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 42: 792-799, 2004
30. Shopsin B, Gomez M, Waddington M, et al: Use of coagulase gene (coa) repeat region nucleotide sequences for typing of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 38: 3453-3456, 2000
31. Cohen P R, Marc E: Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 51: 132-135, 2004
32. Warshawsky B, Hussain Z, Gregson D B, et al: Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 21: 724-727, 2000
33. Bukharie H A, Abdelhadi M S, Saeed I A, et al: Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 40: 1-4, 2001
34. O'Brien F G, Lim T T, Chong F N, et al: Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42: 3185-3190, 2004
35. Frank A L, Marcinak J F, Mangat P D, et al: Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 18: 993-1000, 1999
36. Fergie J E, Purcell K: Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J 20: 860-863, 2001
37. Purcell K, Fergie J E: Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 21: 988-989, 2002
38. Cohen P R, Kurzrock R: Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol 50: 277-280, 2004
39. Baggett H C, Hennessy T W, Rudolph K, et al: Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 189: 1565-1573, 2004
40. Centers for Disease Control and Prevention: Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. JAMA 289: 1377, 2003
41. Dominguez T J: It's not a spider bite, it's community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract 17: 220-226, 2004
42. Denis O, Malaviolle X, Titeca G, et al: Emergence of Panton-Valentine leukocidin positive community-acquired MRSA infections in Belgium. Euro Surveill Wkly 8: issue 24, 2004
43. Liassine N, Auckenthaler R, Descombes M C, et al: Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 42: 825-828, 2004
44. Peleg A Y, Munckhof W J: Fatal necrotising pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA). Med J Aust 181: 228-229, 2004
45. Murray R J, Lim T T, Pearson J C, et al: Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int J Infect Dis 8: 275-283, 2004
46. Lina G, Piémont Y, Godail-Gamot F, et al: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128-1132, 1999
47. Boussaud V, Parrot A, Mayaud C, et al: Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus . Intensive Care Med 29: 1840-1843, 2003
48. Le Thomas I, Mariani-Kurkdjian P, Collignon A, et al: Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia. J Clin Microbiol 39: 728-729, 2001
49. Couppié P, Cribiér B, Prévost G, et al: Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 130: 1208-1209, 1994
50. Andersen B M, Bergh K, Steinbakk M, et al: A Norwegian nosocomial outbreak of methicillin-resistant Staphylococcus aureus resistant to fusidic acid and susceptible to other antistaphylococcal agents. J Hosp Infect 41: 123-132, 1999
51. Saiman L, O'Keefe M, Graham P L 3rd, et al: Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37: 1313-1319, 2003
52. O'Brien F G, Lim T T, Chong F N, et al: Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42: 3185-3190, 2004
53. Baba T, Takeuchi F, Kuroda M, et al: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819-1827, 2002
54. Gillet Y, Issartel B, Vanhems P, et al: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759, 2002
55. Ichiyama S, Ohta M, Shimokata K, et al: Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 29: 2690-2695, 1991
56. Jarraud S, Mougel C, Thioulouse J, et al: Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles, and human disease. Infect Immun 70: 631-641, 2002
57. Strommenger B, Cuny C, Werner G, et al: Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups. Eur J Clin Microbiol Infect Dis 23: 15-19, 2004
58. Novick R P: Pathogenicity factors and their regulation. In Gram-positive pathogens (Fischetti V A, Novick R P, Ferretti J J, et al eds, p. 392-407, American Society for Microbiology, Washington, D. C., 2000
59. Shopsin B, Gomez M, Montgomery S O, et al: Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 37: 3556-3563, 1999
60. Goh S H, Byrne S K, Zhang J L, et al: Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 30: 1642-1645, 1992
61. Bohach G A, Foster T J: Staphylococcus aureus exotoxins. In Gram-positive pathogens (Fischetti V A, Novick R P, Ferretti J J, et al eds, p. 367-378, American Society for Microbiology, Washington, D. C., 2000
62. Kaneko J, Kamio Y: Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68: 981-1003, 2004
63. Couppie P, Cribier B, Prevost G: Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 130: 1208-1209, 1994
64. Prévost G, Cribier B, Couppié P, et al: Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 63: 4121-4129, 1995
65. Gravet A, Couppie P, Meunier O, et al: Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and lukE-lukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol 39: 4349-4356, 2001
66. Kaneko J, Kimura T, Narita S, et al: Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene 215: 57-67, 1998
67. Narita S, Kaneko J, Chiba J, et al: Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus : molecular analysis of a PVL-converting phage, phiSLT. Gene 268: 195-206, 2001
68. Kaneko J, Kimura T, Kawakami Y, et al: Panton-Valentine leukocidin genes in a phage-like particle isolated from mitomycin C-treated Staphylococcus aureus V8 (ATCC 49775). Biosci Biotechnol Biochem 61: 1960-1962, 1997
69. Takahashi N, Nishida H, Kato H, et al: Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351: 1614-1619, 1998
70. Takizawa Y, Shimizu T, Iwaya A, et al: A multiple superantigentic toxin pattern of methicillin-resistant Staphylococcus aureus (MRSA as a risk factor in the development of toxic shock syndrome (TSS). Acta Medica Biol 51: 141-147, 2003
71. Letertre C, Perelle S, Dilasser F, et al: Identification of a new putative enterotoxin SEU encoded by the egc cluster of Staphylococcus aureus. J Appl Microbiol 95: 38-43, 2003
72. Holtfreter S, Bauer K, Thomas D, et al: Egc-encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun 72: 4061-4071, 2004
73. Bergdoll M S, Crass B A, Reiser R F, et al: A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 1017-1021, 1981
74. Bergdoll M S, Schlievert P M: Toxic shock syndrome toxin. Lancet 2: 691, 1984
75. Bohach G A, Fast D J, Nelson R D, et al: Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17: 251-272, 1990
76. Kain K C, Schulzer M, Chow A W: Clinical spectrum of nonmenstrual toxic shock syndrome (TSS: comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 16: 100-106, 1993
77. Jarraud S, Cozon G, Vandenesch F, et al: Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 37: 2446-2449, 1999
78. Fey P D, Said-Salim B, Rupp M E, et al: Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47: 196-203, 2003
79. Kondo I, Sakurai S, Sarai Y, et al: Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. J Clin Microbiol 1: 397-400, 1975
80. Piémont Y, Rifai S, Monteil H: Les exfoliatines de Staphylococcus aureus. Bull Inst Pasteur 86: 263-296, 1988
81. Takizawa Y, Taneike I, Nakagawa S, et al: Molecular DNA analysis of methicillin-resistant Staphylococcus aureus (MRSA) infection in a neonatal intensive care unit. Acta Med Biol 51: 103-109, 2003
82. Koning S, van Belkum A, Snijders S, et al: Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B panton-valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol 41: 3017-3021, 2003
83. Liassine N, Auckenthaler R, Descombes M C, et al: Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 42: 825-828, 2004
84. Pearman J W, Grubb W B: Emerging strains of multiresistant methicillin-resistant Staphylococcus aureus threaten success of screening policy. APUA 11: 1-8, 1993
85. Udo E E, Pearman J W, Grubb W B: Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 26: 157-165, 1994
86. Riley T V, Carson C F, Bowman R A, et al: Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 161: 397-398, 1994
87. Baker C J, Frenck R W: Change in management of skin/soft tissue infections needed. AAP News 25: 105-117, 2004
88. Sattler C A, Mason E O Jr, Kaplan S L: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 21: 910-917, 2002
89. Gauduchon V, Cozon G, Vandenesch F, et al: Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189: 346-353, 2004